Volume | 30,765 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 5.4589 | Mínimo Máximo |
|||||
Minimo del Dia | 5.2201 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Annovis Bio Inc | ANVS | NYSE | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
5.29 | 5.2201 | 5.4589 | 5.31 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
135 | 30,765 | US$ 5.30 | US$ 162,990 | - | 4.79 - 22.49 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
08:55:08 | 374 | US$ 5.36 | USD |
Información Financiera Annovis Bio Inc ANVS
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
56.44M | 10.26M | - | 0 | -56.2M | -5.48 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Annovis Bio Inc ANVS
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
13/6/2024 | 05:05 | Edgar (US Regulatory) | Form 8-K - Current report |
11/6/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
05/6/2024 | 15:32 | Edgar (US Regulatory) | Form 8-K - Current report |
21/5/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
21/5/2024 | 06:30 | GlobeNewswire Inc. | Annovis Announces New Publication in a Peer-Reviewed Journal |
13/5/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
13/5/2024 | 06:30 | GlobeNewswire Inc. | Annovis Bio Provides Corporate Updates and Announces First.. |
10/5/2024 | 16:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/5/2024 | 15:03 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 06:30 | GlobeNewswire Inc. | Annovis Announces Unblinding of the Buntanetap Phase III.. |
06/5/2024 | 16:12 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
06/5/2024 | 16:11 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos ANVS
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 6.43 | 6.43 | 5.2201 | 5.62 | 172,523 | -1.07 | -16.64% |
1 Month | 7.85 | 7.88 | 5.2201 | 6.37 | 236,190 | -2.49 | -31.72% |
3 Months | 12.00 | 20.00 | 4.79 | 7.77 | 555,904 | -6.64 | -55.33% |
6 Months | 11.10 | 22.49 | 4.79 | 9.63 | 425,021 | -5.74 | -51.71% |
1 Year | 14.23 | 22.49 | 4.79 | 9.55 | 253,566 | -8.87 | -62.33% |
3 Years | 92.50 | 132.00 | 4.79 | 28.54 | 194,341 | -87.14 | -94.21% |
5 Years | 8.9875 | 132.00 | 2.418 | 31.33 | 276,412 | -3.63 | -40.36% |